Risk Factors for <i>Pneumocystis jiroveci</i> Pneumonia in Glomerulonephritis Patients Receiving Immunosuppressants-Reference-Cited by-同舟云学术

Risk Factors for Pneumocystis jiroveci Pneumonia in Glomerulonephritis Patients Receiving Immunosuppressants

Published:2012 Issue:20 Volume:51 Page:2869-2875
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yang Chih-Yu¹²,Yang An-Hang³²,Yang Wu-Chang¹²,Lin Chih-Ching¹²

Affiliation:

1. Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taiwan

2. School of Medicine, National Yang-Ming University, Taiwan

3. Department of Pathology, Taipei Veterans General Hospital, Taiwan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/20/51_51.6774/_pdf

Reference24 articles.

1. 1. Lertnawapan R, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Rheumatol Int 29: 491-496, 2009.

2. 2. Ognibene FP, Shelhamer JH, Hoffman GS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 151 (3 Pt 1): 795-799, 1995.

3. 3. Jarrousse B, Guillevin L, Bindi P, et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 11: 615-621, 1993.

4. 4. Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis 5: 41-59, 2011.

5. 5. Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23: 1186-1188, 1996.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection;Journal of Fungi;2023-07-31

2. Association between the cumulative dose of glucocorticoids before the development of pneumonia and death in patients receiving long-term glucocorticoids: a secondary analysis based on a Chinese cohort study;Frontiers in Medicine;2023-07-20

3. Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning–based approach;European Journal of Clinical Microbiology & Infectious Diseases;2023-02-01

4. Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients;Avicenna Journal of Medicine;2023-01

5. Infectious complications in adult patients with idiopathic minimal change nephrotic syndrome undergoing immunosuppressive therapy;Nephrology;2022-10-19